Drug protein conjugates—III. Inhibition of the irreversible binding of ethinylestradiol to rat liver microsomal protein by mixed-function oxidase inhibitors, ascorbic acid and thiols-Reference-Cited by-同舟云学术

Drug protein conjugates—III. Inhibition of the irreversible binding of ethinylestradiol to rat liver microsomal protein by mixed-function oxidase inhibitors, ascorbic acid and thiols

Published:1983-09 Issue:3 Volume:19 Page:1273-1278
ISSN:0022-4731
Container-title:Journal of Steroid Biochemistry
language:en
Short-container-title:Journal of Steroid Biochemistry

Author:

Maggs J.L.,Grabowski P.S.,Park B.K.

Publisher

Elsevier BV

Subject

Endocrinology,Biochemistry

Reference16 articles.

1. Irreversible protein binding of ethinylestradiol in vivo and in vitro;Kappus;Steroids,1973

2. The metabolic fate of mestranol and ethinylestradiol in humans;Bolt;J. steroid Biochem.,1974

3. Oxidative metabolism and de-ethynylation of 17α-ethinylestradiol by baboon liver microsomes;Helton;Steroids,1977

4. An immunochemical study of the hapten formed from ethinylestradiol and guinea pig liver microsomes;Park;FEBS Letters,1978

5. Antiethinylestradiol antibody activities in oral contraceptive users;Beaumont;Clin. exp. Immunol.,1979

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What’s been Hapten-ing over the last 88 years?;Medicinal Chemistry Research;2023-06-15

2. Formation of Both Heme and Apoprotein Adducts Contributes to the Mechanism-Based Inactivation of Human CYP2J2 by 17α-Ethynylestradiol;Drug Metabolism and Disposition;2018-03-30

3. Impact of combined oral contraceptives containing ethinylestradiol on the liver microsomal metabolism;The European Journal of Contraception & Reproductive Health Care;2013-05-06

4. Cytochrome P450 Oxidation of the Thiophene-Containing Anticancer Drug 3-[(Quinolin-4-ylmethyl)-amino]-thiophene-2-carboxylic Acid (4-Trifluoromethoxy-phenyl)-amide to an Electrophilic Intermediate;Chemical Research in Toxicology;2008-08-01

5. Many Drugs and Phytochemicals Can Be Activated to Biological Reactive Intermediates;Current Drug Metabolism;2008-05-01